A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma

被引：0
|
作者：
Shuji Hiramoto
Ken Kato
Hirokazu Shoji
Natsuko Okita
Atsuo Takashima
Yoshitaka Honma
Satoru Iwasa
Tetsuya Hamaguchi
Yasuhide Yamada
Yasuhiro Shimada
Narikazu Boku
机构：
[1] National Cancer Center Hospital,Gastrointestinal Medical Oncology Division
[2] Mitsubishi Kyoto Hospital,Department of Clinical Oncology and Palliative Medicine
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Metastatic/recurrent esophageal cancer; First-line chemotherapy; 5-Fluorouracil + cisplatin; Prognostic factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：466 / 472
页数：6
相关论文
共 50 条
  • [31] Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma
    Mitsuhiro Sugawara
    Chikatoshi Katada
    Natsuya Katada
    Kaoru Takahashi
    Katsuhiko Higuchi
    Shouko Komori
    Hiromitsu Moriya
    Hiromichi Ishiyama
    Keishi Yamashita
    Shinichi Sakuramoto
    Satoshi Tanabe
    Wasaburo Koizumi
    Kazuo Yago
    Esophagus, 2013, 10 : 65 - 69
  • [32] Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma
    Sugawara, Mitsuhiro
    Katada, Chikatoshi
    Katada, Natsuya
    Takahashi, Kaoru
    Higuchi, Katsuhiko
    Komori, Shouko
    Moriya, Hiromitsu
    Ishiyama, Hiromichi
    Yamashita, Keishi
    Sakuramoto, Shinichi
    Tanabe, Satoshi
    Koizumi, Wasaburo
    Yago, Kazuo
    ESOPHAGUS, 2013, 10 (02) : 65 - 69
  • [33] CISPLATIN PLUS 5-FLUOROURACIL IN THE TREATMENT OF METASTATIC ANAL SQUAMOUS-CELL CARCINOMA - A REPORT OF 2 CASES
    KHATER, R
    FRENAY, M
    BOURRY, J
    MILANO, G
    NAMER, M
    CANCER TREATMENT REPORTS, 1986, 70 (11): : 1345 - 1346
  • [34] DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma
    Kim, S.
    Jary, M.
    Mansi, L.
    Benzidane, B.
    Cazorla, A.
    Demarchi, M.
    Nguyen, T.
    Kaliski, A.
    Delabrousse, E.
    Bonnetain, F.
    Letondal, P.
    Bosset, J. F.
    Valmary-Degano, S.
    Borg, C.
    ANNALS OF ONCOLOGY, 2013, 24 (12) : 3045 - 3050
  • [35] CISPLATIN AND 5-FLUOROURACIL CHEMOTHERAPY IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    MERCIER, RJ
    NEAL, GD
    MATTOX, DE
    GATES, GA
    POMEROY, TC
    VONHOFF, DD
    CANCER, 1987, 60 (11) : 2609 - 2612
  • [36] Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer
    Moon, Joon Ho
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Baek, Jin Ho
    Cho, Yoon Young
    Chae, Yee Soo
    Ahn, Byung Min
    Kim, Shi Nae
    Lee, Soo Jung
    Lee, In Taek
    Choi, Gyu Seog
    Jun, Soo Han
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (03) : 400 - 404
  • [37] Oxaliplatin Combined with Continuous Infusion of 5-Fluorouracil as First-Line Chemotherapy in Patients with Metastatic or Recurrent Gastric Adenocarcinoma
    Lim, Jae Yun
    Cho, Jae Yong
    Oh, Kyung Jin
    Choi, Seung Ho
    Lee, Sang In
    Jeung, Hei-Cheul
    CHEMOTHERAPY, 2009, 55 (04) : 200 - 206
  • [38] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
  • [39] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [40] First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial
    Guo, Y.
    Luo, Y.
    Zhang, Q.
    Huang, X.
    Li, Z.
    Shen, L.
    Feng, J.
    Sun, Y.
    Yang, K.
    Ge, M-H.
    Zhu, X.
    Wang, L.
    Liu, Y.
    He, X.
    Bai, C.
    Xue, K.
    Zeng, Y.
    Cao, Y.
    Chen, W.
    Lin, T.
    ANNALS OF ONCOLOGY, 2018, 29
12345